全文获取类型
收费全文 | 6280篇 |
免费 | 332篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 125篇 |
妇产科学 | 89篇 |
基础医学 | 639篇 |
口腔科学 | 103篇 |
临床医学 | 380篇 |
内科学 | 1923篇 |
皮肤病学 | 62篇 |
神经病学 | 652篇 |
特种医学 | 170篇 |
外科学 | 770篇 |
综合类 | 40篇 |
一般理论 | 5篇 |
预防医学 | 419篇 |
眼科学 | 255篇 |
药学 | 418篇 |
1篇 | |
中国医学 | 16篇 |
肿瘤学 | 511篇 |
出版年
2023年 | 46篇 |
2022年 | 85篇 |
2021年 | 221篇 |
2020年 | 109篇 |
2019年 | 185篇 |
2018年 | 204篇 |
2017年 | 159篇 |
2016年 | 160篇 |
2015年 | 172篇 |
2014年 | 215篇 |
2013年 | 341篇 |
2012年 | 488篇 |
2011年 | 469篇 |
2010年 | 280篇 |
2009年 | 247篇 |
2008年 | 427篇 |
2007年 | 441篇 |
2006年 | 431篇 |
2005年 | 378篇 |
2004年 | 281篇 |
2003年 | 302篇 |
2002年 | 266篇 |
2001年 | 79篇 |
2000年 | 57篇 |
1999年 | 49篇 |
1998年 | 61篇 |
1997年 | 42篇 |
1996年 | 36篇 |
1995年 | 29篇 |
1994年 | 24篇 |
1993年 | 15篇 |
1992年 | 40篇 |
1991年 | 30篇 |
1990年 | 22篇 |
1989年 | 30篇 |
1988年 | 26篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 14篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1982年 | 18篇 |
1981年 | 13篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1974年 | 7篇 |
排序方式: 共有6642条查询结果,搜索用时 312 毫秒
81.
Pablo M. Munarriz Ana M. Castaño-Leon Rafael Martinez-Perez Aurelio Hernandez-Lain Ana Ramos Alfonso Lagares 《Neurocirugía (Asturias, Spain)》2013,24(5):220-224
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system, characterized by focal neurological dysfunction with a relapsing and remitting course. Tumor-like presentation of MS (or “tumefactive”/“pseudotumoral” presentation) has been described before with a certain frequency; it consists of a large single plaque (>2 cm) with presence of edema and mass effect and it is hard to distinguish from a brain tumor. However, we present a very rare case of a 53-year-old woman with a right temporal mass that turned out to be a MS plaque, who deteriorated within hours (brain herniation with loss of consciousness and unilateral mydriasis) and required an emergency craniotomy. We also present a review of the literature. It appears that only 4 cases of emergency craniotomy/craniectomy required in a patient with a tumor-like MS plaque have been reported before. 相似文献
82.
Lucely Cetina Tania Crombet Roberto Jiménez-Lima Sergio Zapata Mayra Ramos Sandra Avila Jaime Coronel Eduardo Charco Rafael Bojalil Horacio Astudillo Blanca Bazán Alfonso Due?as-González 《Cancer biology & therapy》2015,16(5):684-689
Nimotuzumab is a humanized IgG1 monoclonal antibody against the EGFR extracellular domain that has been evaluated in solid tumors as a single agent or in combination with chemotherapy and radiation. Cervical cancer patients who are refractory or progressive to first-line chemotherapy have a dismal prognosis, and no second- or third-line chemotherapy is considered standard. This pilot trial aimed to evaluate the efficacy and safety of nimotuzumab in 17 patients with pre-treated advanced refractory or progressive cervical cancer. Nimotuzumab was administered weekly at 200 mg/m2 as single agent for 4 weeks (induction phase), then concurrent with 6 21-day cycles of gemcitabine (800 mg/m2) or cisplatin (50 mg/m2) for 18 weeks (concurrent phase) and then once every 2 weeks (maintenance phase). Nimotuzumab could be continued beyond disease progression. Seventeen patients were accrued and evaluated for safety and efficacy. The median number of nimotuzumab applications was 20 (5–96). The median number of chemotherapy cycles administered was 6 (1-6). No toxicity occurred during induction and maintenance phases (single agent nimotuzumab). In the concurrent phase, grade 3 toxicity events observed were leucopenia, anemia and diarrhea in 11.7%, 5.8% and 11.7% respectively. No complete or partial responses were observed. The stable disease (SD) rate was 35%. The median PFS and OS rates were163 days (95% CI, 104 to 222), and 299 days (95% IC, 177 to 421) respectively. Nimotuzumab is well tolerated and may have a role in the treatment of advanced cervical cancer. 相似文献
83.
Cristina Martínez González Amador Prieto González Lucía García Alfonso Luis Fernández Fernández Ariel Moreda Bernardo Ramon Fernández Álvarez Valeria Rolle-Sóñora Alberto Ruano Raviña Pere Casan Clarà 《Archivos de bronconeumología》2019,55(9):459-464
IntroductionSilicosis is a chronic progressive disease caused by inhalation of crystalline silica. Most cases develop in underground mine workers and in subjects involved in the extraction of natural stone (slate and granite). In view of the progressive emergence of new cases of silicosis in artificial quartz conglomerate workers, we performed a study to analyze the characteristics of silicosis produced by this new agent in Spain.MethodsThe study consisted of a series of 96 cases of silicosis diagnosed according to international criteria during the period 2010-2017. We analyzed clinical, radiological, pathological and functional characteristics.ResultsMean age of participants was 45 years; 55% had simple silicosis and 45% had complicated silicosis. Ten patients were diagnosed with accelerated silicosis, with a mean age of 33 years. Mean time of exposure to conglomerates was 15 years, and 77% had not used appropriate protection measures. Half of the patients were asymptomatic and presented different classic forms on chest X-ray and chest high-resolution computed tomography, along with ground-glass images. No lung function changes were recorded.ConclusionsSilicosis in artificial quartz conglomerate workers occurs in a young, actively employed population, a considerable percentage of whom present an accelerated form. They have few symptoms and no functional limitations. Protection measures are scarce. It is important to characterize these features to provide early diagnosis and implement the necessary preventive measures. 相似文献
84.
85.
86.
87.
María Lourdes Ruiz Rebollo Rocío Aller De La FuenteAna Macho Conesa Inés Salado ValdiviesoMaría Sainz Gil Alfonso CarvajalJosé Manuel González 《Gastroenterologia y hepatologia》2011,34(7):474
Drug-induced hepatotoxicity is a challenge in daily clinical practice. One of the most frequent causes is antibiotics. However, amoxicillin-induced liver injury is uncommon. We report the case of an 87-year-old man who developed cholestatic hepatitis after ingesting amoxicillin 500 mg/8 hours for dental disease. A review of the literature on this topic is provided. 相似文献
88.
89.
90.
Zehra N. Pamuklar Jiegen Chen Michael Muehlbauer Anna Spagnoli Alfonso Torquati 《Surgery for obesity and related diseases》2013,9(1):94-99
BackgroundThe insulin-like growth factor-1 (IGF-1) signaling pathway promotes adipocyte differentiation and, therefore, insulin sensitivity by suppression of necdin expression, which represses peroxisome proliferator-activated receptor-gamma promoter activity by interaction with E2F4 in mouse adipocytes. The aim of the present study was to test the hypothesis that this pathway represents one of the mechanisms by which Roux-en-Y gastric bypass surgery (RYGB) induces resolution of insulin resistance.MethodsClinical samples were collected and the key biomarkers measured to test the hypothesis that the IGF-1 pathway represents 1 of the mechanisms by which RYGB induces resolution of insulin resistance in obese individuals.ResultsFree IGF-1 levels were significantly greater in the post-RYGB patients than in the pre-RYGB obese patients (2.55 ± 1.54 versus 1.32 ± .65 μg/L, P = .03) and similar to that in normal weight controls (2.54 ± 1.27 μg/L). Necdin and E2F4 gene expression in the adipose tissue was significantly downregulated after RYGB compared with obese and were similar to the levels observed in the controls. In mature human adipocytes cultured in vitro, treatment with des-IGF-1 induced downregulation of necdin and E2F4 gene expression in a dose-dependent manner (P = .01).ConclusionAfter RYGB, the insulin/IGF-1 signaling pathway is activated and could account for the observed decrease in the expression of necdin, which represses peroxisome proliferator-activated receptor-gamma promoter activity by interaction with E2F4. This could represent one of the mechanisms that induce resolution of insulin resistance after RYGB. 相似文献